Vanhoutte Paul (182 results)

hardcover. Condition: Good. Connecting readers with great books since 1972! Used textbooks may not include companion materials such as access codes, etc. May have some wear or writing/highlighting. We ship orders daily and Customer Service is our top priority.

Condition: Good. Former library copy. Pages intact with minimal writing/highlighting. The binding may be loose and creased. Dust jackets/supplements are not included. Includes library markings. Stock photo provided. Product includes identifying sticker. Better World Books: Buy Books. Do Good.

gebundene Ausgabe. Condition: Gut. 337 Seiten; Der Erhaltungszustand des hier angebotenen Werks ist trotz seiner Bibliotheksnutzung sauber. Es befindet sich neben dem Rückenschild lediglich ein Bibliotheksstempel im Buch; ordnungsgemäß entwidmet. Einbandkanten sind leicht bestoßen. In ENGLISCHER Sprache. Sprache: Englisch Gewicht in Gramm: 880.…

Hard Cover. Condition: Good. No Jacket. Good condition. Clean text, shaken spine. Some corner and edge wear. Ownership stamps on the FEP and text blocks. Size: 8vo - over 7¾" - 9¾" tall.

Cloth Hard Cover. Condition: Fine. Fine Dust Jacket. (16)288pp. References & index. Tables & charts. Crisp unread condition.

Hardcover. Condition: As New. Leichte Kratzer / Abnutzungen / Druckstellen. Understanding the nature and role of endothelium-derived hyperpolarizing factor appears to be crucial in the quest for improved treatments for hypertension, diabetes, ischemia-reperfusion and other vascular disorders. EDHF 2002 contains the proceedings of the Fourth International Symposium on endothelium-dependent hyperpolarizations and will be of interest not only to physiologists and pharmacologists puzzled by the complexity of the interactions between the endothelium and underlying vascular smooth muscle cells, but also clinical researchers and physicians treating patients with cardiovascular diseases.…

Hardcover. Condition: Near Fine. 380555091X. Pictorial board hardcover, from closed pharmaceutical company library. Lending record shows this book has never been borrowed. 338 pages, index, illustrated with charts, tables and diagrams. Contents clean, tight and bright. Book.

Hardcover. Condition: Very Good. 380555091X. Pictorial board hardcover, from closed pharmaceutical company library. 338 pages, index, illustrated with charts, tables and diagrams. Contents clean, tight and bright. Book.

gebundene Ausgabe. Condition: Gut. 288 Seiten; Das hier angebotene Buch stammt aus einer teilaufgelösten wissenschaftlichen Bibliothek und trägt die entsprechenden Kennzeichnungen (Rückenschild, Instituts-Stempel.); leichte altersbedingte Anbräunung des Papiers; der Buchzustand ist ansonsten ordentlich und dem Alter entsprechend gut. Sprache: Englisch Gewicht in Gramm: 800.…

Hardcover. Condition: Very Good. Dust Jacket Condition: Very Good. 3805528418. Pharmaceutical company library hardcover. 307 pages, subject and author index, illustrated with charts, tables and diagrams. Symposium at Wilrijk 1977. Sections include: Intrinsic Factors; Modulation; Therapeutic Agents; Local factors; Neurogenic Vasodilation. Contents clean, tight and bright. NB, This NOT Biodiversity Conservation in Costa Rica, which may have the same ISBN number. Book. …

Hard Cover. Condition: Very Good+. Dust Jacket Condition: Very Good. First. No internal inscriptions. Interior very clean. Exterior boards very clean. Dustwrapper not price clipped but has minor rips at top of spine Quantity Available: 1. Shipped Weight: Under 1 kilogram. Category: Medicine & Health; ISBN: 0881671010. ISBN/EAN: 9780881671018. Pictures of this item not already displayed here available upon request. Inventory No: 000635. …

Hardcover. Condition: Near Fine. No Jacket. 0897664191. Blue cloth hardcover, from closed pharmaceutical company library. 802 pages, index. Contents clean, tight and bright, appears unread. Book.

Hardcover. Condition: Good. No Jacket. First Edition. From a University library with the usual stamps and labels. Some light wear and a pale splashmark on the front board. A00002049.

Hardcover. Condition: Very Good. Scarce hardcover, x + 134 pages, glossy paper, index, NOT ex-library. Interior in very good condition: clean, bright, untanned, with unmarked text and tight binding, free of readily noticeable creasing. Boards gently shelfworn showing short creases/bumps to edges and wrinkles to spine ends, faint marks and scratches, limited scuffing. Published without a dust jacket. --- The data presented and discussed in this monograph support the concept of heart rate reduction as a valuable therapeutic option for reducing morbidity and mortality in a wide range of cardiovascular disease. Clinical evidence has been accumulating for many years to suggest a link between heart rate and mortality in patients with coronary artery disease, as well as in the general population. Epidemiologic data, particularly from the Framingham study, have also indicated a strong link between sudden cardiac death and sustained elevated heart rate, raising the issue that slow heart rate per se might exert an antifibrillatory action. In this respect, an elevated heart rate can be considered as an independent risk factor for cardiovascular mortality. There is also evidence to suggest that a sustained elevated heart rate may play a direct role in the pathogenesis of coronary atherosclerosis. It is widely accepted that lowering heart rate can reduce the risk of cardiovascular events and increase life expectancy.The heart rate-lowering effects of beta blockers have been correlated with reduced cardiovascular and total mortality in post-myocardial infarction and heart failure patients. In theory, a highly specific heart rate-lowering agent should have the same beneficial effects with respect to reduced risk and mortality and may avoid some of the drawbacks associated with beta blocker therapy. The objectives of current therapies are to increase coronary blood flow and decrease myocardial oxygen demand. Heart rate is a critical determinant of myocardial oxygen consumption and a reduction in heart rate usually leads to a reduction in myocardial oxygen consumption. Coronary blood flow can be improved by a slower heart rate due to an increase in diastolic perfusion time during the heart cycle. The role of specific heart rate-lowering agents needs to be explored in this context.…

Condition: Fine. Amsterdam 1999. Harwood. Hardcover. Sm.4to., 436pp., illus., index, printed boards. Fine. as new.

Condition: As New. Unread book in perfect condition.

First edition. Red cloth-covered boards, gilt spine lettering, 9 1/2 x 6 1/4 inches, 288 pp., references (extensive; pp. 231-280), index, figures and tables. Book and dustcover fine. Multiple contributors.

Condition: New.

Condition: New.

xv + 288pp.with ills., cart.with dustwrapper, VG.

Condition: New.

Condition: New. In.

Condition: New. In.

PF. Condition: New.

PF. Condition: New.

Condition: New. 1st edition NO-PA16APR2015-KAP.

Hardcover. Condition: Good. Good condition (stain on cover, book itself in good condition) Hardcover, no dust jacket.

Condition: As New. Unread book in perfect condition.

Condition: New.

Condition: New. In.